Back to speakers



City: Paris

Institution: Hôpital Beaujon


Biography of Tarik ASSELAH

Tarik Asselah is a Professor of Medicine and Hepatology at Hôpital Beaujon, Clichy, and at the University Paris Diderot, France. Tarik Asselah is the Head of Viral Hepatitis at INSERM (UMR 1149, Centre de Recherche sur l’Inflammation). He has a medical degree in gastroenterology & hepatology and also holds a PhD in virology.

His fields of research include chronic liver diseases, translational medicine and treatment of HBV and HCV with new direct-acting antivirals, for which he has been involved as a principal investigator in pivotal clinical trials. He has published more than 200 articles in the field of viral hepatitis (H-index = 50).





PHC's participations

12th PHC – 2019

Tuesday, January 15th 2019

Targets and new drugs for HBV

11th PHC – 2018

Monday, January 15th 2018

HEPATITIS C - SESSION 1 (chairman)

Treatment of HCV: 100 % cure ? -

Luncheon workshops - -

10th PHC – 2017

Monday, January 30th 2017

Universal Hepatitis C treatment: strategies for simplification -


9th PHC – 2016

Monday, January 11th 2016

State of the art lecture (chairman) -

How to improve the therapeutic strategies? -

Tuesday, January 12th 2016

Lunch Workshops - Room 253 -

8th PHC – 2015

Monday, January 12th 2015

State of the art lecture (chairman) -

INF-free therapy in naïve patients -

Take home messages (chairman) -

Tuesday, January 13th 2015

State of the art lecture (chairman)

Lunch Workshops - Room 253 (chairman)

Take home message (chairman)

7th PHC – 2014

Monday, January 13th 2014

State of the art lecture and Award (chairman)

Genotype 4 -

Advantages of 2nd generation triple therapy -

Tuesday, January 14th 2014

Interactive luncheons - Room 6 (chairman)

6th PHC – 2013

Monday, January 14th 2013

State of the art lecture (chairman)

Interactive luncheons - Room 6 (chairman)

IFN-free regimens -

5th PHC – 2012

Monday, January 30th 2012

Interactive luncheons - Room 7 (chairman)

Tuesday, January 31st 2012

State of the Art Lecture (chairman)

State of the Art Lecture (chairman)

Advantages of new generation DAAs -

4th PHC – 2011

Monday, January 17th 2011

Advantages of new generation DAAs ? -

Tuesday, January 18th 2011

State of the Art lecture (chairman)

3rd PHC – 2009

Monday, January 19th 2009

New drugs : Enzyme inhibitors -